STOCK FUTURES CLIMB AS RATE-HIKE FEARS FADE, WITH APPLE ON DECK

Wall Street bracing for drop in revenue, potentially hefty pullback in iPhone sales in China

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

1.6500

+0.1900

(+13.01%)

At close: 04:00PM EDT

1.6706

+0.02

(+1.25%)

Pre-Market:

09:13AM EDT

Insider Roster

Individual or Entity	Most Recent Transaction	Date	Shares Owned as of Transaction Date
AJER JEFF ROBERT Director	Sale	Sept 17, 2023	34,153
CHESS ROBERT BRUCE Director	Sale	Sept 21, 2022	291,273
CURET MYRIAM J Director	Sale	Sept 17, 2023	27,418
EASTHAM KARIN Director	Stock Award(Grant)	Sept 15, 2022	23,233
GREER R SCOTT Director	Stock Award(Grant)	Sept 15, 2022	303,574
ROBIN HOWARD W Chief Executive Officer	Sale	Feb 19, 2024	880,299
THOMSEN JILLIAN B Chief Financial Officer	Sale	Feb 15, 2023	313,497
WHITFIELD ROY ALEC Director	Sale	Jun 13, 2023	287,750
WILSON MARK ANDREW Officer	Sale	Feb 19, 2024	236,674
ZALEVSKY JONATHAN Officer	Sale	Feb 19, 2024	265,025
*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.